Richmond Pharmacology has appointed Adam Hurd as Operations Director. Hurd will lead the company’s operational directorate, focusing on continually improving how studies are delivered and supporting teams across the organisation.
Hurd brings over two decades of experience leading teams in complex healthcare organisations, with expertise spanning operational delivery, organisational growth and service transformation.
Hurd has spent almost twenty years leading and growing healthcare services within the UK’s National Health Service (NHS). During this time, he founded and led a successful healthcare organisation, overseeing its growth into a business delivering more than 400,000 patient consultations each year across primary and secondary care services.
Hurd was previously a member of Richmond’s Senior Leadership team between 2003 and 2006, where he played a key role in rebuilding the participant recruitment function, strengthening organisational performance and leading the company’s early brand development.
Ulrike Lorch, Chief Clinical and Operations Officer and Co-Founder of Richmond Pharmacology, said: “Adam was part of Richmond during our formative years and understands the values that have shaped the organisation. Over the past two decades, he has built extensive operational leadership experience in healthcare, making him ideally placed to help us strengthen our operations.”
Hurd commented: “The opportunity to help improve how we deliver clinical research, while supporting the development of new medicines for patients, is incredibly motivating. “
Richmond Pharmacology is a London-based clinical research organisation specialising in early-phase clinical trials.